These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 17340045

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tumor necrosis factor-alpha antagonist-induced sarcoidosis.
    Clementine RR, Lyman J, Zakem J, Mallepalli J, Lindsey S, Quinet R.
    J Clin Rheumatol; 2010 Sep; 16(6):274-9. PubMed ID: 20808167
    [Abstract] [Full Text] [Related]

  • 3. Sarcoidosis occuring during anti-TNF-alpha treatment for inflammatory rheumatic diseases: report of two cases.
    Toussirot E, Pertuiset E, Kantelip B, Wendling D.
    Clin Exp Rheumatol; 2008 Sep; 26(3):471-5. PubMed ID: 18578973
    [Abstract] [Full Text] [Related]

  • 4. Development of sarcoidosis 6-month post discontinuation of etanercept: coincidence or real association?
    Haroon M, Ryan JG, Harney S.
    Clin Rheumatol; 2011 Aug; 30(8):1095-8. PubMed ID: 21380931
    [Abstract] [Full Text] [Related]

  • 5. Development of sarcoidosis during etanercept therapy.
    Ishiguro T, Takayanagi N, Kurashima K, Matsushita A, Harasawa K, Yoneda K, Tsuchiya N, Miyahara Y, Yamaguchi S, Yano R, Tokunaga D, Saito H, Ubukata M, Yanagisawa T, Sugita Y, Kawabata Y.
    Intern Med; 2008 Aug; 47(11):1021-5. PubMed ID: 18520114
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pulmonary nodulosis and aseptic granulomatous lung disease occurring in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha-blocking agent: a case series.
    Toussirot E, Berthelot JM, Pertuiset E, Bouvard B, Gaudin P, Wendling D, le Noach J, Lohse A, Lecuyer E, Cri L.
    J Rheumatol; 2009 Nov; 36(11):2421-7. PubMed ID: 19797509
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept.
    Lee JH, Slifman NR, Gershon SK, Edwards ET, Schwieterman WD, Siegel JN, Wise RP, Brown SL, Udall JN, Braun MM.
    Arthritis Rheum; 2002 Oct; 46(10):2565-70. PubMed ID: 12384912
    [Abstract] [Full Text] [Related]

  • 10. TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists.
    Williams VL, Cohen PR.
    Int J Dermatol; 2011 May; 50(5):619-25. PubMed ID: 21506984
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
    Strangfeld A, Listing J, Herzer P, Liebhaber A, Rockwitz K, Richter C, Zink A.
    JAMA; 2009 Feb 18; 301(7):737-44. PubMed ID: 19224750
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The efficiency of switching from infliximab to etanercept and vice-versa in patients with rheumatoid arthritis.
    Cohen G, Courvoisier N, Cohen JD, Zaltni S, Sany J, Combe B.
    Clin Exp Rheumatol; 2005 Feb 18; 23(6):795-800. PubMed ID: 16396697
    [Abstract] [Full Text] [Related]

  • 15. Development of sarcoidosis following etanercept treatment: a report of three cases.
    Skoie IM, Wildhagen K, Omdal R.
    Rheumatol Int; 2012 Apr 18; 32(4):1049-53. PubMed ID: 20062997
    [Abstract] [Full Text] [Related]

  • 16. Systemic sarcoidosis induced by etanercept: first Brazilian case report.
    Unterstell N, Bressan AL, Serpa LA, Fonseca e Castro PP, Gripp AC.
    An Bras Dermatol; 2013 Apr 18; 88(6 Suppl 1):197-9. PubMed ID: 24346918
    [Abstract] [Full Text] [Related]

  • 17. Development of exclusively cutaneous sarcoidosis in patient with rheumatoid arthritis during treatment with etanercept.
    Vieira MA, Saraiva MI, Silva LK, Fraga RC, Kakizaki P, Valente NY.
    Rev Assoc Med Bras (1992); 2016 Nov 18; 62(8):718-720. PubMed ID: 27992009
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge.
    van der Stoep D, Braunstahl GJ, van Zeben J, Wouters J.
    J Rheumatol; 2009 Dec 18; 36(12):2847-8. PubMed ID: 19966199
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.